ACE and meningioma: The prorenin receptor, angiotensin converting enzyme, ATIIR1, and ATIIR2, which are components of the RAS, were expressed on the stem cell population in meningiomas, suggesting that these stem cells may be a potential therapeutic target through the inhibition of the RAS [45,47].